Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kai‐Cheng Peng"'
Autor:
Kai‐Cheng Peng, Jun‐Wei Su, Zhi Xie, Han‐Min Wang, Mei‐Mei Fang, Wen‐Feng Li, Yu‐Qing Chen, Xu‐Hui Guan, Jian Su, Hong‐Hong Yan, Xu‐Chao Zhang, Hai‐Yan Tu, Qing Zhou, Hua‐Jun Chen, Yi‐Long Wu, Jin‐Ji Yang
Publikováno v:
Thoracic Cancer, Vol 13, Iss 11, Pp 1619-1630 (2022)
Abstract Background MET dysregulation has been implicated in the development of primary and secondary resistance to EGFR tyrosine kinase inhibitor (TKI) therapy. However, the clinicopathological characteristics and outcomes of patients harboring EGFR
Externí odkaz:
https://doaj.org/article/82192f83a6d54e8a9200d4bcfce4e18f
Autor:
Kai-Cheng Peng, 彭凱誠
105
Currently hovercraft has been widely developed in the world and was divided into 2 main types: Air cushion vehicle (ACV) and sidewall hovercraft. The development of ACV of mainland China focuses on improving shipping capacity and performance
Currently hovercraft has been widely developed in the world and was divided into 2 main types: Air cushion vehicle (ACV) and sidewall hovercraft. The development of ACV of mainland China focuses on improving shipping capacity and performance
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/7emvv5
Autor:
Bao Ting Zhu, Qiu-Mei Deng, Hua-Jun Chen, Wen-Zhao Zhong, Wenxian Wang, Jin Kang, Chuang-Zhou Rao, Kai-Cheng Peng, Jin-Ji Yang, Chunwei Xu, Peng Li, Xiang-Peng Chu, Pan Wang, Hua-Fei Chen
Publikováno v:
Genes, Chromosomes and Cancer. 61:177-186
Anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) respond well to ALK tyrosine kinase inhibitors (TKIs), and echinoderm microtubule-associated protein-like 4 (EML4)-ALK-rearranged NSCLC accounts for the majority of those
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40b36fea77826cf4fe008238a087858e
https://doi.org/10.1002/gcc.23005
https://doi.org/10.1002/gcc.23005
Autor:
Han-Min Wang, Chan-Yuan Zhang, Kai-Cheng Peng, Ze-Xin Chen, Jun-Wei Su, Yu-Fa Li, Wen-Feng Li, Qing-Yun Gao, Shi-Ling Zhang, Yu-Qing Chen, Qing Zhou, Cong Xu, Chong-Rui Xu, Zhen Wang, Jian Su, Hong-Hong Yan, Xu-Chao Zhang, Hua-Jun Chen, Yi-Long Wu, Jin-Ji Yang
Publikováno v:
Cell Reports Medicine. 4:100911
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2643ef6370e78af9d9e06bb66c709997
https://doi.org/10.1016/j.xcrm.2022.100911
https://doi.org/10.1016/j.xcrm.2022.100911
Autor:
Chan-Yuan Zhang, Han-Min Wang, Kai-Cheng Peng, Ze-Xin Chen, Jun-wei Su, Yuqing Chen, Qing-Yun Gao, Shi-Ling Zhang, Chongrui Xu, Jian Su, Hong-Hong Yan, Xuchao Zhang, Hua-Jun Chen, Jin-Ji Yang
Publikováno v:
Journal of Clinical Oncology. 40:9136-9136
9136 Background: Lung cancer organoids (LCOs) were expected to be the potential precision medicine approach for clinical response prediction. However, the clinical applications of both tissue and malignant serous effusions (MSE) derived LCOs were rar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e278434241d1227ebee778a93e45231
https://doi.org/10.1200/jco.2022.40.16_suppl.9136
https://doi.org/10.1200/jco.2022.40.16_suppl.9136
Autor:
Kejun Liu, Quanquan Tan, Kai-Cheng Peng, Shiyuan Chen, Junwei Su, Chanyuan Zhang, Yuqing Chen, Ligang Wu, Xue Zheng, Hongbo Zheng, Beibei Mao, Shihao Zhang, Jun Jia, Jin-Ji Yang
Publikováno v:
Journal of Clinical Oncology. 40:e21107-e21107
e21107 Background: As the standard first-line treatment for NSCLC patients with EGFR-sensitive mutation, epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) were proved to be highly effective and less toxic compared to traditional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2372c53dce5dcc634b4953d278925d9c
https://doi.org/10.1200/jco.2022.40.16_suppl.e21107
https://doi.org/10.1200/jco.2022.40.16_suppl.e21107